MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • All Meetings
    • 2026 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2026 International Congress

    The Challenges for Diagnosis of Movement Disorders in Ukraine

    Y. Trufanov, N. Khanenko, M. Trishchynska, Y. Tarasenko, T. Voronova-Smolyannikova, A. Galusha, N. Pavliuk, A. Ovchynnykova, R. Sulik, V. Sereda, L. Zviahina, A. Babirad, V. Dubynetska, K. Bakum, V. Yevdokymov, A. Mykhailenko, K. Moisieieva, Z. Tyzhuk, N. Vintoniv-Trushyk, Y. Compta (Kyiv, Ukraine)

    Objective: The purpose of our study was to identify the main problems faced by general neurologists (GN) when diagnosing movement disorders (MD) in Ukraine. Background:…
  • 2026 International Congress

    Dopamine Receptor Blocking Drug Exposure is Associated with Parkinson’s Disease

    L. Neilson, R. Carnahan, V. Kijewski, S. Duffy, G. Scott, N. Narayanan, J. Simmering (Iowa City, USA)

    Objective: To test the hypothesis that dopamine receptor blocking agents (DRBAs) contribute to the later diagnosis of Parkinson’s disease (PD). Background: Recent evidence suggests that…
  • 2026 International Congress

    PPAR-γ-dependent Neuroprotection by Ferulic acid improves Motor deficits in 3-nitropropionic acid model of Huntington’s disease in rats

    N. Singh, V. Singh (bathinda, India)

    Objective: This study investigates the neuroprotective role of FA in  3-nitropropionic acid (3-NP) model of HD through PPAR-γ–mediated mechanisms. Background: Huntington disease (HD) is a…
  • 2026 International Congress

    Diagnosing Prodromal Synucleinopathies – What is the Role of Cardiac MIBG Scintigraphy?

    G. Chiaro, Z. Jiang, A. Rogeau, J. Bomanji, V. Iodice (London, United Kingdom)

    Objective: We aimed to characterize cardiac MIBG uptake patterns in patients with an initial diagnosis of PAF (iPAF) and assess their role as a prognostic…
  • 2026 International Congress

    Incidence and movement disorders associated with Steroid-Responsive Encephalopathy Associated with Autoimmune Thyroiditis (SREAT) in the Princess Maha Chakri Sirindhorn Medical Center (MSMC)

    K. Methawasin, N. Suthumchai, N. Wangwiwatcharoen, K. Anuroj (Nakhon Nayok, Thailand)

    Objective: To identify incidence and clinical features of SREAT patients in MSMC. Background: SREAT patients could present with encephalopathy with various neurological abnormalities, including behavioral…
  • 2026 International Congress

    Risk factors for dysautonomic fluctuations in Mexican PwP

    MF. Medina-Pérez, MF. Velasco-Delgado, A. Cervantes-Arriaga, R. Solís-Vivanco, M. Rodríguez-Violante (Mexico City, Mexico)

    Objective: To identify risk factors for non-motor dysautonomic fluctuations in people living with Parkinson’s disease (PwP). Background: Advanced Parkinson’s disease (PD) is characterized by motor…
  • 2026 International Congress

    Cognitive Progression in Elderly Essential Tremor Patients: Evidence from an 18-Month Prospective Cohort

    E. Abed (Cairo, Egypt)

    Objective: Essential tremor (ET) is one of the most prevalent neurological disorders and has increasingly been linked to cognitive dysfunction. However, most existing data regarding…
  • 2026 International Congress

    Survival and Related Factors in Patients with Parkinson’s Disease : A Multicenter Prospective Cohort Study in China

    S. Song, L. Xiang, Y. Liu, H. Pan, Y. Wu, X. Li, F. Luo, C. Wang, L. Lei, L. Yao, Y. Zhao, Z. Liu, Q. Sun, J. Guo, B. Tang, I. Wu, L. Yin, X. Zhou, Q. Xu (Changsha, China)

    Objective: To estimate mortality, standardized mortality ratios (SMRs), causes of death, and survival-related risk factors in a large, multicenter Parkinson’s disease (PD) cohort from the…
  • 2026 International Congress

    Evaluation of Swallowing and Cough Function in older Patients with Parkinson’s Disease

    M. Nakamori, M. Toko, H. Yamada, R. Matsuyama, Y. Hayashi, M. Yoshikawa, T. Nagasaki, H. Maruyama (Hiroshima, Japan)

    Objective: This study aimed to characterize swallowing and cough function in older patients with Parkinson’s disease (PD) using a multidimensional assessment. Background: With population aging,…
  • 2026 International Congress

    Efficacy of Aripiprazole on Cognitive Functions in Parkinson’s Disease: A Systematic Review and Meta-analysis

    I. Serag (Mansoura, Egypt)

    Objective: To systematically evaluate and quantitatively synthesize evidence on the effect of Aripiprazole on cognitive functions in patients with Parkinson’s disease. Background: Cognitive impairment is…
  • « Previous Page
  • 1
  • …
  • 101
  • 102
  • 103
  • 104
  • 105
  • …
  • 1942
  • Next Page »

Related Sites

International Parkinson and Movement Disorder Society

The Society that manages the annual International Congress »

International Congress

The official website for the International Congress of Parkinson’s and Movement Disorders® »

  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley